The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Select Medical Holdings Corp

NYSE: SEM
Last

(U.S.) $8.62

Today's change-0.48 -5.27%
Updated February 5 4:04 PM EST. Delayed by at least 15 minutes.
 

Select Medical Holdings Corp

NYSE: SEM
Last

(U.S.) $8.62

Today's change-0.48 -5.27%
Updated February 5 4:04 PM EST. Delayed by at least 15 minutes.

Select Medical Holdings Corp down (U.S.)$0.48

Select Medical Holdings Corp closed sharply lower Friday, dropping (U.S.)$0.48 or 5.27% to (U.S.)$8.62. Over the last five days, shares have lost 9.55% and sit 1.17% above their 52-week low. This security has underperformed the S&P 500 by 29.58% during the last year.

Key company metrics

  • Open(U.S.) $9.04
  • Previous close(U.S.) $9.10
  • High(U.S.) $9.09
  • Low(U.S.) $8.52
  • Bid / Ask-- / --
  • YTD % change-27.62%
  • Volume1,534,194
  • Average volume (10-day)1,173,502
  • Average volume (1-month)1,122,583
  • Average volume (3-month)1,087,351
  • 52-week range(U.S.) $8.52 to (U.S.) $17.20
  • Beta1.32
  • Trailing P/E8.92×
  • P/E 1 year forward9.54×
  • Forward PEG0.95×
  • Indicated annual dividend--
  • Dividend yield4.40%
  • Trailing EPS(U.S.) $0.97
Updated February 5 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.96%

Based on its net profit margin of 3.96%, Select Medical Holdings Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue1,021887795772
Total other revenue--------
Total revenue1,021887795772
Gross profit120143131115
Total cost of revenue901744664656
Total operating expense973802716714
Selling / general / administrative40363440
Research & development--------
Depreciation / amortization31221717
Interest expense (income), net operating--------
Unusual expense (income)--000
Other operating expenses, total--------
Operating income48857958
Interest income (expense), net non-operating-33-25-21-21
Gain (loss) on sale of assets--------
Other--------
Income before tax51646039
Income after tax33403728
Income tax, total18242312
Net income29373526
Total adjustments to net income-1-1-1-1
Net income before extra. items29373526
Minority interest-3-3-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items28363425
Inc. avail. to common incl. extra. items28363425
Diluted net income28363425
Dilution adjustment------0
Diluted weighted average shares128128128127
Diluted EPS excluding extraordinary itemsvalue per share0.220.280.270.20
Dividends per sharevalue per share0.000.000.100.10
Diluted normalized EPSvalue per share0.220.280.270.20